Doing even more research on the topic, this was just released a couple hours ago from CNN Money:
Embryonic stem cells might hold the secrets to curing paralysis and brain damage, but they’ve also garnered plenty of controversy with the anti-abortion lobby because they’re harvested from embryos.
However, work using adult stem cells – which are donated by grown men and women – is not only free of such controversy, it’s actually much closer to getting effective products on the market.
The adult stem cell research at several biotech outfits in particular – Osiris, Cytori, Aastrom – is worth keeping an eye on according to analysts.
“From a Wall Street perspective, adult stem cells are a much better investment,” said Stephen Dunn of Dawson James Securities. “These are the guys who are going to be in the news in 2007 and 2008.”
According to the report, while embryonic stem cell researchers are experimenting with rats, adult stem cell researchers have moved on to more advanced tests with humans. The embryonic-based stem cell treatments are probably a decade away, but the US market could see its first adult-based stem cell treatments within the next couple of years.
That’s exciting and something I would be willing to throw tax payer money behind.
